Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alireza Bozorgmanesh

Vascular & Interventional Radiology Daytona Beach, FL Medical Doctor

NPI 1518054535 CMS profile 158830

1673 Mason Ave, Suite 305, Daytona Beach, FL 32117

Open in the dashboard

General payments

$15,435

118 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alireza Bozorgmanesh of Daytona Beach, FL is reported in the CMS Open Payments database as having received $15,435 across 118 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,700 11
2024 General $247 9
2023 General $1,038 22
2022 General $3,827 16
2021 General $5,107 22
2020 General $717 9
2019 General $1,799 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alireza Bozorgmanesh
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Alireza Bozorgmanesh were reported at $2,700. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Alireza Bozorgmanesh Vascular & Interventional Radiology median Middle half National median
2019 $1,799 $422 $125–$1,555 $163
2020 $717 $200 $68–$652 $114
2021 $5,107 $280 $99–$866 $132
2022 $3,827 $433 $137–$1,497 $149
2023 $1,038 $506 $152–$2,019 $160
2024 $247 $556 $175–$1,930 $164
2025 $2,700 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $9,441 17 payments
  2. Penumbra, Inc. $1,716 17 payments
  3. Boston Scientific Corporation $1,421 22 payments
  4. Biocompatibles, Inc. $995 5 payments
  5. Stryker Corporation $544 9 payments
  6. Inari Medical, Inc. $233 3 payments
  7. Siemens Medical Solutions USA, Inc. $207 5 payments
  8. Novartis Pharmaceuticals Corporation $175 10 payments
  9. Argon Medical Devices, Inc. $109 1 payment
  10. Imperative Care, INc $108 3 payments
  11. Other $487 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,235 4 payments
  2. Food and Beverage $4,610 108 payments
  3. Travel and Lodging $2,591 6 payments
Products named General payments · program years 2019–2025
  1. KYPHON Balloon Kyphoplasty $4,698 7 payments
  2. OSTEOCOOL RF ABLATION SYSTEM $4,599 5 payments
  3. Indigo System $1,554 12 payments
  4. THERASPHERE - BIO Interventional Oncology $949 2 payments
  5. THERASPHERE - BIO Interventional Oncology $604 2 payments
  6. IVS - VERTEBRAL AUGMENTATION PRODUCTS $279 1 payment
  7. CT THROMBECTOMY SYSTEM KIT $233 3 payments
  8. FLOWTRIEVER CATHETER, S $233 3 payments
  9. SPINEJACK $205 5 payments
  10. General - Vascular Intervention $195 3 payments
  11. Other $2,231 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 209 billing codes

Paid by Medicare

$198,002

Of which drugs: $1,746

Medicare patients

1,744

Average age 75

Services billed

18,698

951 women, 793 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Ischemic heart disease 48%
COPD 40%
Chronic kidney disease 39%
Diabetes 34%
Depression 31%
Atrial fibrillation 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 197 16,306 $1,725

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

118 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record